Human exposure to polyhalogenated hydrocarbons and incidence of selected malignancies -central European experience.

[1]  A. Sasco.  Cancer and globalization. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  V. Bencko,et al.  Exposure of breast-fed children in the Czech Republic to PCDDs, PCDFs, and dioxin-like PCBs. , 2004, Environmental toxicology and pharmacology.

[3]  J. Cerhan,et al.  Environmental exposure to PCBs and cancer incidence in eastern Slovakia. , 2004, Chemosphere.

[4]  D. Hunter,et al.  Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  M. van den Berg,et al.  In vitro antiestrogenic effects of aryl methyl sulfone metabolites of polychlorinated biphenyls and 2,2-bis(4-chlorophenyl)-1,1-dichloroethene on 17beta-estradiol-induced gene expression in several bioassay systems. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  A. Kočan,et al.  Environmental contamination with polychlorinated biphenyls in the area of their former manufacture in Slovakia. , 2001, Chemosphere.

[7]  I. Costabeber,et al.  Breast cancer risk factors: PCB congeners , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  S. Safe,et al.  Mechanisms of Inhibitory Aryl Hydrocarbon Receptor-Estrogen Receptor Crosstalk in Human Breast Cancer Cells , 2000, Journal of Mammary Gland Biology and Neoplasia.

[9]  P. Boyle,et al.  Breast cancer risk associated with congeners of polychlorinated biphenyls. , 2000, American journal of epidemiology.

[10]  N. Dubin,et al.  Risk of breast cancer and organochlorine exposure. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  J. Brock,et al.  Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  S. Safe,et al.  Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. , 1998, Toxicology letters.

[13]  Safe,et al.  Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. , 1998, Environmental health perspectives.

[14]  A. Liem,et al.  Selected polyhalogenated hydrocarbons in breast milk. , 1998, Toxicology letters.

[15]  K. Failing,et al.  Chlororganic Pesticides and Polychlorinated Biphenyls in Breast Tissue of Women with Benign and Malignant Breast Disease , 1998, Archives of environmental contamination and toxicology.

[16]  Jochen F Mueller,et al.  Levels of PCBs, PCDDs and PCDFs in human milk , 2003 .

[17]  R. Letcher,et al.  Effects of brominated flame retardants on activity of the steroidogenic enzyme aromatase (CYP19) in H295R human adrenocortical carcinoma cells in culture , 2003 .

[18]  A. Miller,et al.  Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  S. Safe,et al.  Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. , 1997, Toxicology and applied pharmacology.

[20]  S. Safe,et al.  Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. , 1994, Critical reviews in toxicology.